22 August 17
Invest in the first Chinese pharmaceutical company to list on the ASX:
Haixi Pharmaceutical International Holdings Limited ASX: HXP
I invite you to participate in the initial public offering of the first Chinese pharmaceutical company to list on the ASX, Haixi Pharmaceutical International Holdings Limited.
Established in 1995, Haixi is a long-standing, highly recognised and respected brand in the pharmaceutical industry in China. The Company is engaged in the business of manufacturing, sales, R&D of State Food and Drug Administration (SFDA) approved pharmaceutical products, which includes ointment and medicinal creams treating pains, swelling and itching, as well as tablets, capsules and liquids.
Read more here